One of the most difficult challenges with COVID-19 is constant viral evolution. As the virus mutates and infects animals, tracking its changes becomes harder. Current vaccines remain the strongest defense against severe COVID-19 disease. Still, improved vaccine technologies are urgently needed as variants continue emerging.
Researchers recently tested a single-dose intranasal COVID-19 vaccine in animals. They found it effectively prevented coronavirus infection and blocked viral transmission. The research team comes from the University of Hong Kong’s LKS Faculty of Medicine. Their work focuses on preventing future coronavirus outbreaks before they spread.
This new vaccine functions like a Swiss Army knife against coronaviruses. Most existing vaccines primarily protect against one dominant viral strain. This prototype offers broad protection and requires only a single dose.










